HHS logo

Harte Hanks (HHS)

Profile

Full Name

Harte Hanks, Inc.

Ticker Symbol

HHS

Exchange

NASDAQ

Sector

Industrials

Industry

Conglomerates

Country

United States

IPO

November 4, 1993

Indexes

Not included

Website

http://www.hartehanks.com

Employees

1715

Key Details

Price

$4.60(-1.29%)

Market cap

Last Dividend

$0.85

TTM Dividend yield

-

Annual revenue

$185.24M(-3.26% YoY)

Annual EPS

-$4.15(-1876.19% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.60
HHS price is $4.60

30-Day Relative Volume

0.25
HHS 30-day relative volume is 0.25

Price Performance

Price Most recent change

-1.29%
HHS price was down -1.29% on Apr 15, 2025

Price YTD change

-10.68%
HHS price is down -10.68% since January 1st

Price 1-year change

-35.21%
HHS price is down -35.21% year-on-year

Price 3-year change

-40.26%
HHS price is down -40.26% over the past 3 years

Price Range

Price All-time high

$314.70
HHS price is currently -98.54% below its historical high of $314.70

Price 3-year low

$4.27
HHS price is currently +7.73% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$33.84M
HHS market capitalization is $33.84 million

Market cap 3-year change

-37.35%
HHS market capitalization is down -37.35% over the past 3 years

Market cap All-time high

$2.62B
HHS market capitalization is currently -98.71% below its historical high of $2.62 billion

Market cap sector rank

19.52%
HHS market capitalization is higher than 19.52% of companies in Industrials sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.61%
HHS shares outstanding is up +1.61% year-on-year

Shares Outstanding 3-Year Change

+5.07%
HHS shares outstanding is up +5.07% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.55
HHS beta is 0.55

200-day SMA

$6.40
HHS price is currently -28.16% below its 200-day simple moving average

50-day SMA

$4.95
HHS price is currently -7.02% below its 50-day simple moving average

RSI

46.79
HHS 14-day relative strength index is 46.79

Volume

0.25
HHS 30-day relative volume is 0.25

ATR

$0.36
HHS average true range is $0.36

10-day Historical Volatility

73.81%
HHS 10-day historical volatility is 73.81%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.85
HHS last dividend was $0.85 per share, with an ex-dividend date of February 26, 2016

Next Dividend

-
HHS next dividend has not yet been announced

Dividend per share

Dividend per share

-
HHS annual dividend per share value is unknown

Dividend per share Sector Rank

-
HHS annual dividend per share is unknown

Dividend per share 1-Year Change

-
HHS annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
HHS annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
HHS annual dividend yield value is unknown

Dividend yield Sector Rank

-
HHS annual dividend yield is unknown

Other

Payout ratio

-
HHS annual payout ratio value is unknown

Dividends paid

-
HHS annual dividends paid value is unknown

Free cash flow

-$6.73M
HHS annual free cash flow is -$6.73 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$185.24M
HHS annual revenue is $185.24 million

Revenue Analysts estimate

$195.40M
HHS annual revenue is currently -5.20% lower than the consensus analysts' forecast

Revenue 1-year change

-3.26%
HHS annual revenue is down -3.26% year-on-year

Revenue Sector rank

31.07%
HHS annual revenue is higher than 31.07% of companies in Industrials sector

EPS

EPS

-$4.15
HHS annual earnings per share is -$4.15

EPS Analysts estimate

$1.07
HHS annual earnings per share is currently -487.85% lower than the consensus analysts' forecast

EPS 1-year change

-1876.19%
HHS annual earnings per share is down -1876.19% year-on-year

EPS Sector rank

8.41%
HHS annual earnings per share is higher than 8.41% of companies in Industrials sector

Profit

Gross profit

$128.60M
HHS annual gross profit is $128.60 million

Gross margin

69.42%
HHS annual gross profit margin is 69.42%

Operating profit

$7.66M
HHS annual operating income is $7.66 million

Operating margin

4.14%
HHS annual operating profit margin is 4.14%

Net income

-$30.30M
HHS annual net profit is -$30.30 million

Net margin

-16.36%
HHS annual net profit margin is -16.36%

Expenses

Total expenses

$177.58M
HHS annual total expenses is $177.58 million

Operating expenses

$120.94M
HHS annual total operating expenses is $120.94 million

Cost of goods sold

$56.64M
HHS annual cost of goods sold is $56.64 million

Selling, general & administrative expenses

$116.55M
HHS annual SGA is $116.55 million

Depreciation and amortization

$4.38M
HHS annual depreciation & amortization is $4.38 million

Interest expense

-
HHS annual interest expense value is unknown

Income tax

-$7.64M
HHS annual income tax is -$7.64 million

EBIT & EBITDA

EBIT

$7.66M
HHS annual earnings before interest & taxes is $7.66 million

EBITDA

$12.05M
HHS annual EBITDA is $12.05 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$101.78M
HHS annual total assets is $101.78 million

Non current assets

$48.17M
HHS annual long term assets is $48.17 million

Current assets

$53.61M
HHS annual total current assets is $53.61 million

Cash and cash equivalents

$9.93M
HHS annual cash & cash equivalents is $9.93 million

Accounts receivable

$31.65M
HHS annual accounts receivable is $31.65 million

Inventory

-
HHS annual inventory value is unknown

Liabilities

Total liabilities

$80.09M
HHS annual total liabilities is $80.09 million

Long term liabilities

$44.96M
HHS annual total long term liabilities is $44.96 million

Current liabilities

$35.14M
HHS annual total current liabilities is $35.14 million

Accounts payable

$21.83M
HHS annual accounts payable is $21.83 million

Debt

Total debt

$24.60M
HHS annual total debt is $24.60 million

Total debt 1-year change

-13.72%
HHS annual total debt is down -13.72% year-on-year

Long term debt

$20.86M
HHS annual long term debt is $20.86 million

Short term debt

$3.74M
HHS annual short term debt is $3.74 million

Equity & Capital

Shareholders equity

$21.69M
HHS annual stockholders equity is $21.69 million

Book value

$21.69M
HHS annual book value is $21.69 million

Retained earnings

$814.62M
HHS annual retained earnings is $814.62 million

Working capital

$18.48M
HHS annual working capital is $18.48 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.99M
HHS annual cash flow from operations is -$2.99 million

Cash from operations 1-year change

-128.51%
HHS annual cash flow from operations is down -128.51% year-on-year

Cash from investing

-$3.74M
HHS annual cash flow from investing activities is -$3.74 million

Cash from investing 1-year change

-62.15%
HHS annual cash flow from investing activities is down -62.15% year-on-year

Cash from financing

-$419.00K
HHS annual cash flow from financing activities is -$419.00 thousand

Cash from financing 1-year change

+86.97%
HHS annual cash flow from financing activities is up +86.97% year-on-year

CAPEX

CAPEX

$3.75M
HHS annual capital expenditures is $3.75 million

CAPEX 1-year change

+33.21%
HHS annual capital expenditures is up +33.21% year-on-year

Free Cash Flow

Free cash flow

-$6.73M
HHS annual free cash flow is -$6.73 million

Free cash flow 1-year change

-187.84%
HHS annual free cash flow is down -187.84% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

69.42%
HHS annual gross profit margin is 69.42%

Operating margin

4.14%
HHS annual operating profit margin is 4.14%

Net margin

-16.36%
HHS annual net profit margin is -16.36%

ROA & ROE

ROA

-26.99%
HHS annual return on assets is -26.99%

ROE

-145.85%
HHS annual return on equity is -145.85%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
HHS price to earnings ratio value is unknown

PE ratio Sector rank

-
HHS price to earnings ratio is unknown

PB Ratio

PB ratio

1.56
HHS price to book ratio is 1.56

PB ratio Sector rank

47.42%
HHS price to book ratio is higher than 47.42% of companies in Industrials sector

PS Ratio

PS ratio

0.18
HHS price to sales ratio is 0.18

PS ratio Sector rank

8.89%
HHS price to sales ratio is higher than 8.89% of companies in Industrials sector

Enterprise value

Enterprise value

$48.51M
HHS enterprise value is $48.51 million

Enterprise value Sector rank

18.93%
HHS enterprise value is higher than 18.93% of companies in Industrials sector

EV/EBITDA

EV/EBITDA

4.58
HHS EV/EBITDA is 4.58

EV/EBITDA Sector rank

30.82%
HHS EV/EBITDA is higher than 30.82% of companies in Industrials sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.53
HHS annual current ratio is 1.53

Quick ratio

-
HHS annual quick ratio value is unknown

Leverage

Debt to equity

0.00
HHS annual debt to equity ratio is 0.00

Interest coverage ratio

-
HHS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
HHS piotroski f-score is 5

Altman Z-Score

13.74
HHS altman z-score is 13.74

Analyst ratings

Recent major analysts updates

Nov 9, 17 Noble Capital Markets
Buy
Mar 14, 16 BMO Capital
Market Perform
Dec 8, 15 Singular Research
Buy
Jul 21, 15 BMO Capital
Outperform
May 30, 14 BMO Capital
Market Perform
Oct 21, 13 Noble Capital Markets
Hold
Oct 4, 13 BMO Capital
Outperform
Apr 26, 13 Noble Capital Markets
Buy
Feb 1, 13 Noble Capital Markets
Hold
Feb 1, 13 BMO Capital
Market Perform

Institutional Ownership

Similar stocks

BGSF logo
BGSF (BGSF)
LILM logo
Lilium NV (LILM)
New Century Logistics (BVI) Limited (NCEW)
APWC logo
Asia Pacific Wire & Cable Corporation Limited (APWC)
BW logo
Babcock & Wilcox Enterprises (BW)
BWEN logo
Broadwind (BWEN)
Primech Holdings (PMEC)
Safe Pro Group (SPAI)
AGFY logo
Agrify (AGFY)
  • What is the ticker symbol for Harte Hanks?
  • Does Harte Hanks pay dividends?
  • What sector is Harte Hanks in?
  • What industry is Harte Hanks in?
  • What country is Harte Hanks based in?
  • When did Harte Hanks go public?
  • Is Harte Hanks in the S&P 500?
  • Is Harte Hanks in the NASDAQ 100?
  • Is Harte Hanks in the Dow Jones?
  • When was Harte Hanks's last earnings report?
  • When does Harte Hanks report earnings?

What is the ticker symbol for Harte Hanks?

The ticker symbol for Harte Hanks is NASDAQ:HHS

Does Harte Hanks pay dividends?

No, Harte Hanks does not pay dividends

What sector is Harte Hanks in?

Harte Hanks is in the Industrials sector

What industry is Harte Hanks in?

Harte Hanks is in the Conglomerates industry

What country is Harte Hanks based in?

Harte Hanks is headquartered in United States

When did Harte Hanks go public?

Harte Hanks's initial public offering (IPO) was on November 4, 1993

Is Harte Hanks in the S&P 500?

No, Harte Hanks is not included in the S&P 500 index

Is Harte Hanks in the NASDAQ 100?

No, Harte Hanks is not included in the NASDAQ 100 index

Is Harte Hanks in the Dow Jones?

No, Harte Hanks is not included in the Dow Jones index

When was Harte Hanks's last earnings report?

Harte Hanks's most recent earnings report was on Mar 17, 2025

When does Harte Hanks report earnings?

The next expected earnings date for Harte Hanks is May 9, 2025
On this page